These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10894120)

  • 41. Differential effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the olfactory bulb and the striatum in mice.
    Mitsumoto Y; Mori A; Ohashi S; Nakai M; Moriizumi T
    Neurosci Res; 2005 Jan; 51(1):111-5. PubMed ID: 15596247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recovery of motor function and dopaminergic parameters in a mouse model of Parkinson's disease induced by co-administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate.
    Shimazu S; Takahata K; Tamashiro A; Yoneda F; Iida Y; Saji H
    J Neural Transm (Vienna); 2003 Aug; 110(8):871-83. PubMed ID: 12898343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Sugama S; Wirz SA; Barr AM; Conti B; Bartfai T; Shibasaki T
    Neuroscience; 2004; 128(2):451-8. PubMed ID: 15350655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    D'Astous M; Mendez P; Morissette M; Garcia-Segura LM; Di Paolo T
    Mol Pharmacol; 2006 Apr; 69(4):1492-8. PubMed ID: 16434614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The MPTP mouse model: cues on DA release and neural stem cell restorative role.
    Serra PA; Pluchino S; Marchetti B; Desole MS; Miele E
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S189-93. PubMed ID: 18579428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Manganese does not alter the severe neurotoxicity of MPTP.
    Baek SY; Kim YH; Oh SO; Lee CR; Yoo CI; Lee JH; Lee H; Sim CS; Park J; Kim JW; Yoon CS; Kim Y
    Hum Exp Toxicol; 2007 Mar; 26(3):203-11. PubMed ID: 17439923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease.
    Kurkowska-Jastrzebska I; Litwin T; Joniec I; Ciesielska A; Przybyłkowski A; Członkowski A; Członkowska A
    Int Immunopharmacol; 2004 Oct; 4(10-11):1307-18. PubMed ID: 15313429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroprotective mechanism of modafinil on Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Xiao YL; Fu JM; Dong Z; Yang JQ; Zeng FX; Zhu LX; He BC
    Acta Pharmacol Sin; 2004 Mar; 25(3):301-5. PubMed ID: 15000882
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dimebon attenuates methamphetamine, but not MPTP, striatal dopamine depletion.
    Geldenhuys WJ; Darvesh AS; Dluzen DE
    Neurochem Int; 2012 Jun; 60(8):806-8. PubMed ID: 22710395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Consequences of manganese administration for striatal dopamine and motor behavior in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed C57BL/6 mice.
    Dodd CA; Bloomquist JR; Klein BG
    Hum Exp Toxicol; 2013 Aug; 32(8):865-80. PubMed ID: 23263854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative effects of 1-ethyl- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridines on catecholamine concentrations in mouse brain and heart.
    Fuller RW; Hemrick-Luecke SK; Robertson DW
    Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):129-32. PubMed ID: 3258433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased synaptosomal dopamine content and brain concentration of paraquat produced by selective dithiocarbamates.
    Barlow BK; Thiruchelvam MJ; Bennice L; Cory-Slechta DA; Ballatori N; Richfield EK
    J Neurochem; 2003 May; 85(4):1075-86. PubMed ID: 12716439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson's disease.
    Altagracia M; Rojas P; Kravzov J; Rios C
    Proc West Pharmacol Soc; 1993; 36():289-91. PubMed ID: 7690973
    [No Abstract]   [Full Text] [Related]  

  • 54. Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium.
    Miller DB; Reinhard JF; Daniels AJ; O'Callaghan JP
    J Neurochem; 1991 Aug; 57(2):541-9. PubMed ID: 1649252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of the role of multidrug resistance-associated proteins in MPTP neurotoxicity in mice.
    Plangár I; Zádori D; Szalárdy L; Vécsei L; Klivényi P
    Ideggyogy Sz; 2013 Nov; 66(11-12):407-14. PubMed ID: 24555241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice.
    Miville-Godbout E; Bourque M; Morissette M; Al-Sweidi S; Smith T; Mochizuki A; Senanayake V; Jayasinghe D; Wang L; Goodenowe D; Di Paolo T
    PLoS One; 2016; 11(3):e0151020. PubMed ID: 26959819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Time-course and dose-response study on the effects of chronic L-DOPA administration on striatal dopamine levels and dopamine transporter following MPTP toxicity.
    Fornai F; Battaglia G; Gesi M; Giorgi FS; Orzi F; Nicoletti F; Ruggieri S
    Brain Res; 2000 Dec; 887(1):110-7. PubMed ID: 11134595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of chronic angiotensin-converting enzyme inhibition on striatal dopamine content in the MPTP-treated mouse.
    Jenkins TA; Wong JY; Howells DW; Mendelsohn FA; Chai SY
    J Neurochem; 1999 Jul; 73(1):214-9. PubMed ID: 10386973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
    Lau YS; Trobough KL; Crampton JM; Wilson JA
    Gen Pharmacol; 1990; 21(2):181-7. PubMed ID: 2332138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased striatal manganese content in MPTP treated mice.
    Alvarez-Vega R; Rios C; Rojas P; Kravsov J
    Proc West Pharmacol Soc; 1991; 34():497-500. PubMed ID: 1788337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.